Vial

INDIVIDUAL TEST 047

FGFR3 Antibodies (IgG)

Indication

Suspicion of inflammatory sensory neuropathy

Sample material

Serum

  • Minim. volume: 0,5 mL

Transport

  • Within Sweden: room temperature
  • International: cold

Method

ELISA

Reference interval

< 3000 negative

Result

Results are reported as negative or positive with a titer.

Interpretation

Antibodies against Fibroblast Growth Factor (FGFR3) have been reported with sensory neuropathy in patients with autoimmune diseases.

References

  • Antoine JC et al. 2015. Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy. PMID: 25628376
  • Gendre T et al. Neurol Neuroimmunol Neuroinflamm. 2024. Characterizing Acute-Onset Small Fiber Neuropathy. PMID: 38170952
  • Tholance Y et al. J Neurol Neurosurg Psychiatry. 2020. Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies. PMID: 31690697
  • Zeidman LA. Neurol Clin. 2021. Advances in the Management of Small Fiber Neuropathy. PMID: 33223078

Last updated: 2025-10-09

More information

Learn more about sampling.
> Read more

Download request forms

Neurology

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 047

FGFR3-antikroppar (IgG)

Indikation

Misstanke om inflammatoriska sensorisk neuropati

Provmaterial

Serum

  • Minim. volym: 0,5 mL

Transport

  • Inom Sverige: rumstemperatur
  • Internationellt: kylt

Metod

ELISA

Referensintervall

< 3000 negativt

Resultat

Resultat anges som negativt eller positivt med titer.

Tolkning

Antikroppar mot Fibroblast Growth Factor (FGFR3) har rapporterats vid sensorisk neuropati hos patienter med autoimmun systemsjukdom.

Referenser

  • Antoine JC et al. 2015. Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy. PMID: 25628376
  • Gendre T et al. Neurol Neuroimmunol Neuroinflamm. 2024. Characterizing Acute-Onset Small Fiber Neuropathy. PMID: 38170952
  • Tholance Y et al. J Neurol Neurosurg Psychiatry. 2020. Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies. PMID: 31690697
  • Zeidman LA. Neurol Clin. 2021. Advances in the Management of Small Fiber Neuropathy. PMID: 33223078

Senast uppdaterat: 2025-10-09

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Neurologi

Hittar du inte vad du söker? Vi kan hjälpa till